Kenvue’s Plunge: Value Play or Value Trap?
Kenvue, the Johnson & Johnson consumer health spin-off, has seen its stock price collapse amid legal uncertainties and management turmoil. While the company’s strong brand portfolio and cash flow suggest value, significant risks remain for investors considering this dip.
